Ampa Health

Ampa Health is a neurotechnology company founded in 2022 that develops scalable brain stimulation technology for the treatment of depression and other mental health disorders. Its work centres on transcranial magnetic stimulation (TMS), a non-invasive method that delivers magnetic pulses to activate and strengthen brain circuits through neuroplasticity. The company's stated mission is to help one billion people reach remission from mental and neurological disorders.

The firm's main product, Ampa One, is an FDA-cleared TMS system designed to make TMS therapy more affordable and accessible. Built by clinicians for clinicians, the platform is described as simple, lightweight and easy to use. TMS technology of this kind is applied across mental health, healthcare, neurology, psychiatry and addiction treatment.

Scale figures cited for the field include more than 60 million TMS treatments delivered to date and over 3 million patients treated. Ampa Health's stated emphasis is on democratizing access to treatment and on making therapy affordable and straightforward to administer. Further information is available at https://ampahealth.com/.